{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:16:45Z","timestamp":1790108205933,"version":"4.0.1"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>\n                    Myogenic differentiation (MD) has been claimed to be a poor prognostic factor in dedifferentiated liposarcoma (DDLPS). To validate this, the prognostic significance of MD in a uniformly treated cohort of DDLPS was assessed. A cohort of patients that have been uniformly treated at one institution for DDLPS of the retroperitoneum and pelvis were stained with smooth muscle actin (SMA) and desmin and semiquantitatively scored for staining focality and strength. Clinical and survival data was collected, and the prognostic significance of MD was evaluated. A total of 50 patients with uniformly treated DDLPS were evaluated. SMA (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.052) and a combined score of MD (SMA+desmin) showed a statistically significant decrease in 5-year disease-free survival (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.002) in univariate analysis and in multivariate testing combined MD trended toward significance (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.052). Combined MD was associated with a decreased OS in multivariate analysis (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.004). In a uniformly treated cohort of DDLPS stained for myogenic markers, a combined myogenic score was associated with poor overall survival in multivariate analysis. However, the difference in groups was slight and the clinical application is limited.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001436","type":"journal-article","created":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T09:00:40Z","timestamp":1580115640000},"page":"799-804","source":"Crossref","is-referenced-by-count":16,"title":["Prognostic Value of Myogenic Differentiation in Dedifferentiated Liposarcoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Pawel","family":"Kurzawa","sequence":"first","affiliation":[{"name":"Department of Clinical Pathology, Pozna\u0144 University of Medical Sciences"},{"name":"Pathology Department, University Hospital of Lord\u2019s Transfiguration, Partner of Karol Marcinkowski University of Medical Sciences, Pozna\u0144, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Mullen","sequence":"additional","affiliation":[{"name":"Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Johnstone","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Chebib","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P.","family":"Nielsen","sequence":"additional","affiliation":[{"name":"James Homer Wright Pathology Laboratories, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1053\/adpa.2000.8133","article-title":"Liposarcoma: new entities and evolving concepts","volume":"4","author":"Dei Tos","year":"2000","journal-title":"Ann Diagn Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/PAS.0000000000000366","article-title":"Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma","volume":"39","author":"Gronchi","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2559.2001.01152.x","article-title":"Myofibroblastic differentiation in malignant fibrous histiocytoma (pleomorphic myofibrosarcoma): a clinicopathological study","volume":"38","author":"Montgomery","year":"2001","journal-title":"Histopathology"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1200\/JCO.2001.19.12.3045","article-title":"Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification","volume":"19","author":"Fletcher","year":"2001","journal-title":"J Clin Oncol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ejso.2004.07.018","article-title":"Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance","volume":"30","author":"Massi","year":"2004","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e31804b4109","article-title":"Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas","volume":"31","author":"Binh","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.humpath.2014.03.002","article-title":"Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue","volume":"45","author":"Cipriani","year":"2014","journal-title":"Hum Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/cncr.11617","article-title":"Myoid differentiation and prognosis in adult pleomorphic sarcomas of the extremity","volume":"98","author":"Deyrup","year":"2003","journal-title":"Cancer"},{"key":"R11-20230922","first-page":"950.e28","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","year":"2017","journal-title":"Cell"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:34:46Z","timestamp":1695407686000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001436","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,22]]}}}